CTOs on the Move

Respicardia

www.respicardia.com

 
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.respicardia.com
  • 12400 Whitewater Dr Suite 150
    Minnetonka, MN USA 55343
  • Phone: 952.540.4470

Executives

Name Title Contact Details

Funding

Respicardia raised $58.5M on 12/19/2017

Similar Companies

Sterigenics International

Sterigenics International is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

X-Spine Systems

X-Spine Systems is a Miamisburg, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Enlitic

Enlitic is focused on developing solutions that enhance clinical workflows, enable research and development, improve billing accuracy, and decrease risk. We`re not an AI company that only produces algorithms for detection and prioritization of specific diseases – point solutions. We`re a medical intelligence company that delivers solutions with a point; to enable better patient outcomes by enhancing what`s possible in data processes. We are working to eliminate inefficiencies in workflows and ensure medical information is more useful and more impactful for patient care.

LDS Test

LDS Test is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Earlens

Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens® Contact Hearing Solution, which directly vibrates the eardrum with a tiny lens in order to activate the natural hearing process. This revolutionary, nonsurgical hearing solution delivers the broadest bandwidth available today and superior sound quality. The Earlens® Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. We believe that people with hearing loss shouldn`t have to think about their hearing in everyday situations. Earlens was designed specifically to address the sound quality and speech understanding complaints that are common among hearing aid wearers and contribute to non-compliance. We make every Earlens device custom-fit for each patient`s unique anatomy and hearing needs, while offering modern features such as Bluetooth streaming.